SUMMARY Developmental retardation was a prominent clinical feature in six infants from three kindreds deficient in the enzyme purine nucleoside phosphorylase (PNP) and was present before development of T cell immunodeficiency. Guanosine triphosphate (GTP) depletion was noted in the erythrocytes of all surviving homozygotes and was of equivalent magnitude to that found in the Lesch-Nyhan syndrome (complete hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency). The similarity between the neurological complications in both disorders indicates that the two major clinical consequences of complete PNP deficiency have differing aetiologies:
Deficiency of the enzyme purine nucleoside phosphorylase (PNP:EC 2.4.2.1) was first reported in 1975 in a child with recurrent infection and anaemia.' Clinical features in the first nine cases2-4 have invariably been related to a pronounced reduction in T cell numbers and function, with either normal or enhanced B cell function.17 Deoxyguanosine triphosphate (dGTP) has been found in the erythrocytes and implicated in the T cell dysfunction of the disorder. [2] [3] [4] [5] The age at presentation has varied from birth to 6 years. Therapeutic approaches to restore immune competence have usually been unsuccessful. [2] [3] [4] [5] patients have died from viral infection or lymphoma. [1] [2] [3] [4] [5] [6] [7] [8] [9] Successful engraftment after haploidentical bone marrow transplantation has been reported recently in a single case.") This paper compares clinical and biochemical findings in our latest case of PNP deficiency with those in two previous kindreds5 9 and highlights severe developmental retardation as a prominent clinical feature of the disorder. We have also found severe guanosine triphosphate (GTP) depletion in the red cells of all available homozygotes from these kindreds,5 9 1lin addition to the dGTP accumulation noted earlier by others. [2] [3] [4] As the brain has a high requirement for GTP 12 and resembles the human erythrocyte ( Fig. 1 ) in being largely dependent on salvage to maintain GTP concentrations the combined clinical and biochemical findings support a direct relation between the enzyme defect and the neurological dysfunction. They underline the fact that PNP deficiency should be suspected in children with central nervous system (CNS) disorders as well as T cell immunodeficiency and suggest a metabolic basis for this association. 385 Fig. 1 Pathways of purine metabolism, indicating the importance of PNP for the degradation of deoxyribonucleosides derived from the turnover of DNA, as well as ribonucleosides arising from A TP and GTP (all shown in bold) during daily cell turnover. In the absence of PNP (broken arrows) the four PNP substrates indicated accumulate in the plasma and are excreted in urine in place of uric acid. The potential for dGTP formation after deoxyguanosine accumulation when PNP is defective is also shown.
The effect of complete PNP deficiency in restricting substrate availability for HGPRT is evident from the broken line, showing that HGPRT normally plays a vital role in tandem with PNP for guanine recycling and maintenance of GTP concentrations, particularly when de novo synthesis is absent, as in the human erythrocyte, or limited, as in the brain. The importance of extracellular adenosine, and hence adenosine kinase, for maintaining A TP concentrations in the red cell, due to a lack of the normal route of A TP formation from IMP present in nucleated cells, is also indicated. tremor was also present. There was severe developmental retardation, with motor involvement (equal to a child of 1 year) being more severe than intellectual development (equivalent to a child of 2-5 years). The child had started to sit at 1 year and stand at 3 years and walked unsteadily on tiptoe with help at 3 years 9 months. Investigations showed a child with anaemia with a positive result of a direct Coombs test and severe T cell immunodeficiency.9 A computed tomogram of the brain and electroencephalogram yielded normal results. The child subsequently succumbed to viral infection at the age of 4 years 6 months. Permission for postmortem examination was refused.
Family history revealed an elder sister (case 4) who had died at 4 years of chickenpox complicated by pneumonia and carditis and had also been severely developmentally retarded and suffered repeated chest and ear infections. (She was considered a homozygote for PNP deficiency from the similarity in the case history). An 11 month old brother (case 5) showed similar abnormalities to the propositus: CNS involvement was evident from poor head control, generalised hypotonia with inability to stand, and a delay in fine motor milestones. Only limited investigations were permitted, but retardation remains the principal problem. Despite the severe T cell immunodeficiency,9 there have been no episodes of infection over the past 12 months. The presence of normal HGPRT activity in case 6 (Table 1) , as in cases 2, 3, and 5, was also confirmed by studies in intact red cells (results not shown). Of the other purine enzymes, both adenine phosphoribosyltransferase and adenosine deaminase were again raised in case 6 (Table 1) , a finding noted in some but not all homozygotes.' 9 Low S-adenosylhomocysteine hydrolase activities (patient range 1*7-3-0 nmol/mg Hb/h: control range 3-69-0 nmol/mg Hb/h) were also found, as reported earlier by others in this disorder.> 9 16 Extremely low activities of this enzyme were first noted in adenosine deaminase deficiency, the companion purine disorder presenting as severe combined T=Trace.
Family
--Not normally detectable. Table 2 HGPRT deficiency (Lesch-Nyhan syndrome) and tended to reflect the severity of the CNS involvement. Red cell GTP depletion was not found in the four patients with partial HGPRT deficiency in whom CNS function was normal.
Discussion
The purpose of this report was to highlight the neurological abnormalities that were a prominent clinical feature in six patients from three PNP deficient families. It should be emphasised, therefore, that immunodeficiency may not be the presenting symptom in this disorder. Neurological involvement was also present in four of the first nine published cases, but it was questioned whether this was secondary to viral infection, possibly contracted by immunisation with live virus.2 Our observations indicate that CNS viral infection is an unlikely cause of the neurological deficit seen in these patients. Case 2 was investigated from birth and showed head lag and excessive irritability at 3 months. Our latest case had neurological problems that required attendance at a special school, well before the onset of autoimmune disease. These findings suggest an important link between GTP concentrations and normal CNS function. GTP is known to be essential both for sustained macromolecular synthesis and neurotransmission within the CNS. Consequently, restriction of substrate supply to HGPRT, due to defective PNP activity (Fig. 1) , could be as damaging to either of these functions as a defect in HGPRT itself. This hypothesis is supported by the fact that the clinical progress of case 2 bore many similarities to that described for children with the Lesch-Nyhan syndrome, where generalised muscular hypotonia from infancy is considered to be the basic abnormality on which torsion dystonia is subsequently superimposed.'2 HGPRT activity is higher in the CNS than in any other tissue, and in the neonatal period the ratio of HGPRT salvage activity to de novo synthesis increases considerably after the main burst of neuroblast and neuroglial proliferation.'2 The absence of any anatomical or histopathological lesions in the brain in the Lesch-Nyhan syndrome suggests that the enzyme deficiency produces neurological dysfunction by interfering with brain function rather than brain morphogenesis. 12 Extensive neurological investigation in case 2 also revealed no anatomical lesion. This was confirmed at postmortem examination.
The combined clinical and biochemical results suggest that CNS dysfunction in PNP deficiency is a direct consequence of the enzyme defect and relates to an inherent inability to sustain GTP at concentrations essential for normal function, with the red cell, as in HGPRT deficiency, reflecting a wider deficit in tissues, such as brain, that also depend on salvage for maintaining GTP concentrations. Whether the finding of GTP depletion and/or the associated accumulation of deoxyguanosine triphosphate in platelets as well as red cells9 is also important for the immune response is unknown. With the exception of case 6, platelet numbers have been normal, but GTP depletion in vitro has been linked with defective synthesis of deoxyribonucleic acid in lymphoid cells.20 As immunodeficiency is not a facet of the Lesch-Nyhan syndrome, however, it would seem that GTP depletion per se is not implicated in the gradual attrition of T cell function in PNP deficiency.
In summary, this study underlines the fact that immunodeficiency may not necessarily be the presenting abnormality, or of the greatest immediate concern to the family, in patients with PNP deficiency. The enzyme defect should be considered in children with developmental delay and neurological dysfunction. Autoimmune haemolytic anaemia is also a recognised mode of presentation.2' The diagnosis is suggested by the finding of hypouricaemia. Measurement of PNP activity and purine concentrations in body fluids will be essential to confirm the metabolic basis for the defect,2' while red cell GTP concentrations may be a useful guide to the degree of CNS involvement. The studies also indicate that there may be potential hazards associated with the development of PNP inhibitors as immunosuppressants for different malignant states.
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